Barely Significant
← all excerpts

ITGB6 modulates resistance to anti-CD276 therapy in head and neck cancer by promoting PF4<sup>+</sup> macrophage infiltration.

Nat Commun · 2024 · PMC11329676 · PMID 39152118

Europe PMCDOI
1
hedged sentence
—
closest p
—
boldest claim

The sentences

an increasing trendno p-value reported
Overall, we observed an increasing trend of ITGB6 protein levels along with HNSCC development and progression (Supplementary Fig. 5A, B ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.